95 related articles for article (PubMed ID: 8704616)
1. [The pharmacokinetics of propranolol and its conjugated metabolites in patients with chronic ischemic heart disease and arterial hypertension with a one-time and course intake of the drug].
Belolipetskaia VG; Rumiantsev DS; Piotrovskiĭ VK; Metelitsa VI; Duda SG; Ostrovskaia TP; Kokurina EV; Martseva SIu; Bochkareva EV; Filatova NP
Eksp Klin Farmakol; 1995; 58(6):56-9. PubMed ID: 8704616
[TBL] [Abstract][Full Text] [Related]
2. [The absence of stereoselectivity in propranolol uptake by the lungs].
Shvachko EV; Rumiantsev DO; Piotrovskiĭ VK; Mazaev VP
Eksp Klin Farmakol; 1992; 55(6):40-3. PubMed ID: 1305875
[TBL] [Abstract][Full Text] [Related]
3. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
Paradiso-Hardy FL; Walker SE; Bowles SK
Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and metabolism of oral doses of a 4'-methylthio derivative of propranolol in man.
Walle T; Walle UK; Cowart TD; Conradi EC; Gaffney TE
Xenobiotica; 1990 Mar; 20(3):321-31. PubMed ID: 2336841
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
Sica D; Frishman WH; Manowitz N
Heart Dis; 2003; 5(3):176-81. PubMed ID: 12783630
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetic characteristics of propranolol in patients with a history of acute myocardial infarct].
Katrukha SP; Kalenikov EI; Zagrebin SV; Kukes VG
Farmakol Toksikol; 1987; 50(3):87-9. PubMed ID: 3609287
[TBL] [Abstract][Full Text] [Related]
7. [The pharmacokinetics of different drug forms of nifedipine when used singly and in a course as monotherapy and in combination with Cordanum and triampur preparations in patients with arterial hypertension].
Kukes VG; Ignat'ev VG; Pavlov SS; Starodubtsev AK
Eksp Klin Farmakol; 1995; 58(6):22-5. PubMed ID: 8704605
[TBL] [Abstract][Full Text] [Related]
8. [Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris].
Butina EK; Kokurina EV; Dmitrieva NA; Bochkareva EV
Ter Arkh; 2002; 74(9):36-41. PubMed ID: 12418118
[TBL] [Abstract][Full Text] [Related]
9. Enantioselective inhibitory effect of nicardipine on the hepatic clearance of propranolol in man.
Vercruysse I; Belpaire F; Wynant P; Massart DL; Dupont AG
Chirality; 1994; 6(1):5-10. PubMed ID: 8018468
[TBL] [Abstract][Full Text] [Related]
10. [Chronopharmacokinetics of nadolol in patients with arterial hypertension].
Rumiantsev DO; Duda SG; Poteshnykh AV; Piotrovskiĭ VK; Metelitsa VI; Belolipetskaia VG
Eksp Klin Farmakol; 1997; 60(5):47-50. PubMed ID: 9483406
[TBL] [Abstract][Full Text] [Related]
11. [Propranolol binding with plasma proteins and erythrocytes].
Gneushev ET; Mamedov TSh; Gneusheva IA; Sivkov II
Farmakol Toksikol; 1991; 54(1):55-7. PubMed ID: 1860502
[TBL] [Abstract][Full Text] [Related]
12. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
[TBL] [Abstract][Full Text] [Related]
13. [Use of the new beta-adrenoblockader Corgard in ischemic heart disease and arterial hypertension].
Ostapiuk FE; Khvoĭnitskiĭ VA
Sov Med; 1984; (5):87-9. PubMed ID: 6147019
[No Abstract] [Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of propranolol in hypertensive patients after sublingual administration: systemic availability.
Mansur AP; Avakian SD; Paula RS; Donzella H; Santos SR; Ramires JA
Braz J Med Biol Res; 1998 May; 31(5):691-6. PubMed ID: 9698776
[TBL] [Abstract][Full Text] [Related]
15. [Long-term effects of captopril treatment on the course of stable effort angina pectoris and structural-functional characteristics of platelets in patients with hypertension and ischemic heart disease].
Shafer MZh; Gul'tiaeva EP; Gapon LI; Alfimova TV
Ter Arkh; 2001; 73(7):64-7. PubMed ID: 11523414
[TBL] [Abstract][Full Text] [Related]
16. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
[TBL] [Abstract][Full Text] [Related]
17. Enantioselectivity in the steady-state pharmacokinetics of metoprolol in hypertensive patients.
Cerqueira PM; Cesarino EJ; Mateus FH; Mere Y; Santos SR; Lanchote VL
Chirality; 1999; 11(7):591-7. PubMed ID: 10423287
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
19. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
Podoleanu D; Cotoi S
Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
[TBL] [Abstract][Full Text] [Related]
20. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
